Boots Co PLC
27 January 2000
Boots to open stores in Taiwan
The Boots Company today announced plans to trial its Boots
Health and Beauty stores in Taiwan.
Boots will open 5 stores in Taipei by the end of 2000. Total
investment over the next 18 months will be of the order of
Boots has already established retail operations in Asia, with
a growing chain in Thailand and three recently opened pilot
stores in Tokyo.
The Health and Beauty format stores in Taiwan will closely
resemble Boots The Chemists UK stores and those already
established in Asia. Store appearance and layout will be
similar and they will stock OTC medicines and a wide range of
fragrance, cosmetics and toiletries. Merchandise will include
the major Boots brands and exclusives such as No7 cosmetics,
Ruby and Millie cosmetics and Natural Collection toiletries
plus international and leading local brands.
The Boots Company's chairman, Lord Blyth of Rowington said
'Once again we have thoroughly researched the market and
Taiwan represents a great opportunity to extend our
international retail business. We believe that the market has
the potential to support a chain of around 100 Boots stores
and we hope to build on our success in Thailand where we
expect to have 50 stores trading by the end of March.'
For Further Information Contact:
Keith Whitesides Francis Thomas
Director of Investor Relations Group Media Relations Manager
The Boots Company PLC The Boots Company PLC
Tel: 0115 968 7171 Tel: 0115 968 7029
Mobile: 0836 660 700
Notes to Editors:
Taiwan has a population of 22 million mostly living in urban
areas around six major cities. The largest of these, Taipei,
has a population of over 7.5 million (including greater
Taipei). The Taiwanese retail market is worth around £30
billion per year concentrated in the major urban areas and
Taipei in particular.
The cosmetics and toiletries market is valued at around £1
billion (a quarter of the size of the UK market) and is
forecast to achieve growth in excess of 4% p.a. for the next 5
There is no single dominant cosmetics and toiletries retailer.
The country's 60 department stores, dominated by the major
Japanese chains, are the main outlet for premium cosmetics.
Toiletries are sold primarily through the grocery and
drugstore sectors, in which Carrefour and Watson's,
respectively, are the key players.
Management of the Boots Taiwan Business
The Boots Taiwan business will form part of the portfolio of
international retail businesses that comprise Boots Retail
International, a division of The Boots Company PLC.
The managing director of the Boots Taiwan business will be
Martin Waters. Prior to this appointment Mr Waters was the
marketing director of Boots Retail Thailand and previously
held a number of senior positions in Boots The Chemists and
Boots Other Overseas Retail Interests
Thailand: In May 1998 Boots announced plans to open a chain of
Health & Beauty stores in Thailand following a successful year
of trials involving six pilot stores. There are currently 39
The Netherlands: Boots announced plans in January 1999, to
open a chain of Boots Health and Beauty stores in the
Netherlands over the next four years. There are currently 14
Japan: In July 1998 Boots announced plans to establish pilot
stores in Tokyo and 3 stores were opened during the autumn of
Republic of Ireland: Boots opened its first store in Dublin in
1996. Following the acquisition of two pharmacy chains in
1998, Boots is now the largest pharmacy chain in the Irish
Republic with 29 stores.
Boots Other Overseas Operations
Boots Contract Manufacturing (BCM). The largest contract
manufacturer of cosmetics and toiletries in Europe. In
addition to supplying cosmetics, toiletries and medicines to
its sister companies, BCM also develops and manufactures
products for retailers in the UK and overseas. BCM has
manufacturing bases in England, Scotland, France, Germany and
Boots Healthcare International (BHI). Develops and markets
over the counter medicines in over 130 countries world-wide.
Specialising in three core product categories; analgesics,
upper respiratory tract and dermatological skincare, BHI's
best known brands include Nurofen and Strepsils. In recent
years BHI has added to its skincare portfolio with the
acquisition of Lutsia in France and Hermal in Germany.